Diagnostic testing beyond the clinic

Prior to joining Primary.Health as a Medical Director Consultant, Aditya Chandrasekhar, MD, MPH has been at Fenway Health since 2014, first as a Primary Care Physician and as a Lead Physician since 2016. Dr. Chandrasekhar earned his MD from Grant Medical College in Mumbai, India and his MPH from the Johns Hopkins Bloomberg School of Public Health. Dr. Chandrasekhar completed his Internal Medicine Residency at the University of Massachusetts Medical School. He is a Linde Fellow in Primary Care Leadership at Beth Israel Deaconess Medical Center and an Instructor in Medicine at Harvard Medical School. Dr. Chandrasekhar’s areas of clinical interest include LGBTQIA+ health and HIV care.

Rafid Fadul, MD, MBA is a physician and health tech executive who is passionate about leveraging technology for the benefit of the masses.

He is triple board certified (internal medicine, pulmonary medicine, and critical care). He completed his medicine training at Georgetown University while doing his MBA at Johns Hopkins, followed by training in pulmonary/critical care at the Cleveland Clinic. He has published extensively in clinical medicine, health economics, and digital health, and has presented nationally and internationally on the same. Dr. Fadul also serves on the Board of Directors for MedWish International and leads medical missions overseas.

Katie Kowals is a highly experienced multi-state Registered Nurse with over a decade of expertise in Emergency Room medicine and trauma services. With a deep passion for leveraging innovation and technology to provide high-quality healthcare to all, Katie transitioned from the bedside to become a pioneer in tele-health nursing. Drawing on her extensive background in Emergency medicine and community health, Katie brings a wide range of skills to the tele-health space, including patient acuity prioritization, STI testing and counseling, women’s health, and above all, patient safety practices. Through her work, Katie is committed to expanding access to healthcare and improving health outcomes for individuals and communities.

Rachel Keith, Ph.D., APRN, ANP-C is an Associate Professor of Medicine at the University of Louisville School of Medicine and Director of Human Subject Services at the Environment Institute. As a regulatory trained clinician scientist, Dr. Keith combines her diverse skill set in basic sciences, nursing, community participatory research and clinical studies to understand how environmental exposures impact health outcomes, targeting prevention of cardiovascular disease and novel identifiers of early disease. Though genetics plays a role in susceptibility of individuals to disease, a larger portion likely comes from the environment, which can range from lifestyle choices such as physical activity and tobacco use to inhaled compounds such as air pollution or biotics like Sars-CoV02. Her research, including oversight of numerous clinical studies, seeks to establish how the environment influences both disease and the perception of risk, which has many policy and regulatory implications.

Anne Wyllie, PhD, MBioMedSci, BMedSci is a research scientist in the Department of Epidemiology of Microbial Diseases at the Yale School of Public Health at Yale University and is the principal investigator of SalivaDirect. Dr. Wyllie was the lead author of a 2020 research article which led to the development of the SalivaDirect PCR method of testing saliva for SARS-CoV-2, the virus that causes COVID-19. She has also worked on community studies to better understand pneumococcal disease.

Wyllie completed a BSc in Biomedical Science at the University of Auckland in 2007, followed by a Postgraduate Diploma, and Masters in Medical Science in 2009 at the Auckland Cancer Society Research Centre (University of Auckland). She also received a Ph.D. in medical microbiology in 2016 at Utrecht University.